CTRI/2024/07/071545尚未招募4 期
A comparative study of amlodipine and telmisartan to assess the impact on glycemic status, lipid profile and renal parameters in drug naive hypertensive patients in eastern India. - NI
Midnapore medical college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient aged between 18 and 65 years.
- •2.Patients newly diagnosed with hypertension(systolic blood pressure =140 mm hg and/or diastolic pressure =90 mmhg)
- •3.Patients with no history of diabetes mellitus,renal disease or hyperlipidemia.
- •4.Patients who provide informed consent to participate in the study.
排除标准
- •1.Patients who are already taking antihypertensive medications.
- •2.Patients with a history of allergic reactions to amlodipine or telmisartan.
- •3.Patients with a history of chronic diseases,such as diabetes mellitus,renal disease,or hyperlipidemia.
- •5.Pregnant or lactating women.
- •6.Patients who are unable or unwilling to provide informed consent.
- •7.Patients who are not taking any other medications that interfere glycemic status,lipid profile and renal parameters.
研究者
相似试验
已完成
不适用
The comparison of azilsartan and amlodipine for treatment of VEGF receptor-tyrosine kinase inhibitor-induced hypertension in advanced kidney cancer patientsVEGFR-TKI-induced hypertensionJPRN-UMIN000010940Kanazawa University, 13-1 Takaramachi, Kanazawa10
尚未招募
Unknown
Comparative study to assess effectiveness and Safety of Amlodipine and Telmisartan.CTRI/2024/02/062389Dr Reddys Laboratories Ltd
进行中（未招募）
不适用
A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure - TEAMSTA PROTECT I?Male and female, treated and treatment-naive patients with uncontrolled hypertension (defined as 20/10 mmHg above target BP of <140/90 mmHg [<130/80 mmHg for renally impaired and/ or diabetics patients])?Male and female treated patients with controlled hypertension (defined as target BP < 140/90 mmHg [ < 130/80 mmHg for renally impaired and/ or diabetics patients])MedDRA version: 13.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2009-017010-68-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz
Unknown
4 期
Telmisartan, Amlodipine and Flow Mediated DilationHypertensionNCT01180205Johannes Gutenberg University Mainz576
已完成
1 期
Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant UseHealthyNCT02129192Boehringer Ingelheim72